BeOne Medicines president Wu Xiaobin sells $5.85 million in shares

Published 14/11/2025, 23:46
BeOne Medicines president Wu Xiaobin sells $5.85 million in shares

BeOne Medicines Ltd. (EXCHANGE:ONC) President and COO Wu Xiaobin sold 14,153 American Depositary Shares of the company on November 12 and 13, 2025, for a total of $5.85 million. The sales occurred at prices ranging from $350.441 to $381.0497.

Following these transactions, Wu directly owns 1,020,861 ordinary shares, 1,769 American Depositary Shares, and indirectly owns 4,000 American Depositary Shares through his wife. The 1,020,861 ordinary shares includes 650 ordinary shares acquired pursuant to the Company’s Fourth Amended and Restated 2018 Employee Share Purchase Plan. Each American Depositary Share represents 13 Ordinary Shares.

In other recent news, BeOne Medicines reported impressive financial results for the third quarter of 2025. The company achieved a non-GAAP diluted earnings per share (EPS) of $2.65, which significantly exceeded the forecasted $0.80. Additionally, BeOne Medicines surpassed revenue expectations, bringing in $1.41 billion compared to the anticipated $1.37 billion. These results highlight the company’s strong performance in the recent quarter. The earnings and revenue figures are crucial data points for investors assessing the company’s financial health. No recent mergers or acquisitions were reported for BeOne Medicines. Analyst upgrades or downgrades were not mentioned in the latest updates. These recent developments provide investors with a snapshot of BeOne Medicines’ current financial standing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.